Learn more

EPITOPIX LLC

Overview
  • Total Patents
    130
  • GoodIP Patent Rank
    35,666
  • Filing trend
    ⇧ 200.0%
About

EPITOPIX LLC has a total of 130 patent applications. It increased the IP activity by 200.0%. Its first patent ever was published in 1995. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and machines are LINDAHL GUNNAR, ICM CO LTD and APHTON CORP.

Patent filings per year

Chart showing EPITOPIX LLCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Emery Daryll A 87
#2 Straub Darren E 81
#3 Wonderling Laura 46
#4 Herron Olson Lisa L 22
#5 Catron Drew M 19
#6 Herron-Olson Lisa L 15
#7 Emery Daryll 11
#8 Zammert Donavan E 7
#9 Kallevig Gayla K 6
#10 Straub Darren 5

Latest patents

Publication Filing date Title
WO2019147947A2 Engineered proteins and methods of use
MX2019009409A Proteins and immunizing compositions containing pasteurella proteins and methods of use.
US2018064799A1 Polypeptides and immunizing compositions containing Bacillus polypeptides and methods of use
US2019224297A1 Polypeptides of fusobacterium and methods of use
CN107921114A Protein and immune composition and application method comprising Klebsiella albumen
AU2015258239A1 Polypeptides from staphylococcus aureus and methods of use
US2015191510A1 Polypeptides and immunizing compositions containing Burkholderia polypeptides and methods of use
AU2012244060A1 Polypeptides from staphylococcus aureus and methods of use
AU2012202163A1 Yersinia spp. polypeptides and methods of use
AU2010229498A1 Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
NZ597997A Antibody compositions that bind polypeptides from staphylococcus aureus
AU2006206234A1 Yersinia spp. polypeptides and methods of use
MX2007001886A Fusobacterium polypeptides and methods of use.
EP1678316A2 Campylobacter polypeptides and methods of use
EP0749321A1 Active immunization using a siderophore receptor protein